Global Foot and Mouth Disease (FMD) Vaccination market growth is projected to reach  US$ 1122 million in 2025 to US$ 1863 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.

Global Foot and Mouth Disease (FMD) Vaccination Market Trends and Analysis 2025-31

The global Foot and Mouth Disease (FMD) Vaccination market size is predicted to grow from US$ 1122 million in 2025 to US$ 1863 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031. Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Foot and Mouth Disease (FMD) Vaccination Industry Forecast looks at past sales and reviews total world Foot and Mouth Disease (FMD) Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Foot and Mouth Disease (FMD) Vaccination sales for 2025 through 2031. With Foot and Mouth Disease (FMD) Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Foot and Mouth Disease (FMD) Vaccination industry. This Insight Report provides a comprehensive analysis of the global Foot and Mouth Disease (FMD) Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Foot and Mouth Disease (FMD) Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Foot and Mouth Disease (FMD) Vaccination market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Foot and Mouth Disease (FMD) Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Foot and Mouth Disease (FMD) Vaccination. This report presents a comprehensive overview, market shares, and growth opportunities of Foot and Mouth Disease (FMD) Vaccination market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Emergency Vaccines &nbsp;&nbsp;&nbsp; Conventional Vaccines Segmentation by Application: &nbsp;&nbsp;&nbsp; Cattle &nbsp;&nbsp;&nbsp; Pig &nbsp;&nbsp;&nbsp; Sheep & Goat &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Jinyu Group &nbsp;&nbsp;&nbsp; Cavet Bio &nbsp;&nbsp;&nbsp; CAHIC &nbsp;&nbsp;&nbsp; Tecon Group &nbsp;&nbsp;&nbsp; Shen Lian &nbsp;&nbsp;&nbsp; Biogenesis Bag &nbsp;&nbsp;&nbsp; BIGVET Biotech &nbsp;&nbsp;&nbsp; Indian Immunologicals &nbsp;&nbsp;&nbsp; Boehringer Ingelheim &nbsp;&nbsp;&nbsp; MSD Animal Health &nbsp;&nbsp;&nbsp; CEVA &nbsp;&nbsp;&nbsp; Bayer HealthCare &nbsp;&nbsp;&nbsp; VECOL &nbsp;&nbsp;&nbsp; Sanofi (Merial) &nbsp;&nbsp;&nbsp; Brilliant Bio Pharma &nbsp;&nbsp;&nbsp; VETAL &nbsp;&nbsp;&nbsp; BVI &nbsp;&nbsp;&nbsp; LIMOR &nbsp;&nbsp;&nbsp; ME VAC &nbsp;&nbsp;&nbsp; Agrovet Key Questions Addressed in this Report What is the 10-year outlook for the global Foot and Mouth Disease (FMD) Vaccination market? What factors are driving Foot and Mouth Disease (FMD) Vaccination market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Foot and Mouth Disease (FMD) Vaccination market opportunities vary by end market size? How does Foot and Mouth Disease (FMD) Vaccination break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Foot and Mouth Disease (FMD) Vaccination Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccination by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccination by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Foot and Mouth Disease (FMD) Vaccination Segment by Type &nbsp;2.2.1 Emergency Vaccines &nbsp;2.2.2 Conventional Vaccines &nbsp;2.3 Foot and Mouth Disease (FMD) Vaccination Sales by Type &nbsp;2.3.1 Global Foot and Mouth Disease (FMD) Vaccination Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Foot and Mouth Disease (FMD) Vaccination Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Foot and Mouth Disease (FMD) Vaccination Sale Price by Type (2020-2025) &nbsp;2.4 Foot and Mouth Disease (FMD) Vaccination Segment by Application &nbsp;2.4.1 Cattle &nbsp;2.4.2 Pig &nbsp;2.4.3 Sheep & Goat &nbsp;2.4.4 Others &nbsp;2.5 Foot and Mouth Disease (FMD) Vaccination Sales by Application &nbsp;2.5.1 Global Foot and Mouth Disease (FMD) Vaccination Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Foot and Mouth Disease (FMD) Vaccination Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Foot and Mouth Disease (FMD) Vaccination Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Foot and Mouth Disease (FMD) Vaccination Breakdown Data by Company &nbsp;3.1.1 Global Foot and Mouth Disease (FMD) Vaccination Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Foot and Mouth Disease (FMD) Vaccination Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Foot and Mouth Disease (FMD) Vaccination Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Foot and Mouth Disease (FMD) Vaccination Revenue by Company (2020-2025) &nbsp;3.2.2 Global Foot and Mouth Disease (FMD) Vaccination Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Foot and Mouth Disease (FMD) Vaccination Sale Price by Company &nbsp;3.4 Key Manufacturers Foot and Mouth Disease (FMD) Vaccination Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Foot and Mouth Disease (FMD) Vaccination Product Location Distribution &nbsp;3.4.2 Players Foot and Mouth Disease (FMD) Vaccination Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Foot and Mouth Disease (FMD) Vaccination by Geographic Region &nbsp;4.1 World Historic Foot and Mouth Disease (FMD) Vaccination Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Foot and Mouth Disease (FMD) Vaccination Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Foot and Mouth Disease (FMD) Vaccination Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Foot and Mouth Disease (FMD) Vaccination Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Foot and Mouth Disease (FMD) Vaccination Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Foot and Mouth Disease (FMD) Vaccination Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Foot and Mouth Disease (FMD) Vaccination Sales Growth &nbsp;4.4 APAC Foot and Mouth Disease (FMD) Vaccination Sales Growth &nbsp;4.5 Europe Foot and Mouth Disease (FMD) Vaccination Sales Growth &nbsp;4.6 Middle East & Africa Foot and Mouth Disease (FMD) Vaccination Sales Growth 5 Americas &nbsp;5.1 Americas Foot and Mouth Disease (FMD) Vaccination Sales by Country &nbsp;5.1.1 Americas Foot and Mouth Disease (FMD) Vaccination Sales by Country (2020-2025) &nbsp;5.1.2 Americas Foot and Mouth Disease (FMD) Vaccination Revenue by Country (2020-2025) &nbsp;5.2 Americas Foot and Mouth Disease (FMD) Vaccination Sales by Type (2020-2025) &nbsp;5.3 Americas Foot and Mouth Disease (FMD) Vaccination Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Foot and Mouth Disease (FMD) Vaccination Sales by Region &nbsp;6.1.1 APAC Foot and Mouth Disease (FMD) Vaccination Sales by Region (2020-2025) &nbsp;6.1.2 APAC Foot and Mouth Disease (FMD) Vaccination Revenue by Region (2020-2025) &nbsp;6.2 APAC Foot and Mouth Disease (FMD) Vaccination Sales by Type (2020-2025) &nbsp;6.3 APAC Foot and Mouth Disease (FMD) Vaccination Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Foot and Mouth Disease (FMD) Vaccination by Country &nbsp;7.1.1 Europe Foot and Mouth Disease (FMD) Vaccination Sales by Country (2020-2025) &nbsp;7.1.2 Europe Foot and Mouth Disease (FMD) Vaccination Revenue by Country (2020-2025) &nbsp;7.2 Europe Foot and Mouth Disease (FMD) Vaccination Sales by Type (2020-2025) &nbsp;7.3 Europe Foot and Mouth Disease (FMD) Vaccination Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccination by Country &nbsp;8.1.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccination Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccination Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccination Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Foot and Mouth Disease (FMD) Vaccination Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Foot and Mouth Disease (FMD) Vaccination &nbsp;10.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccination &nbsp;10.4 Industry Chain Structure of Foot and Mouth Disease (FMD) Vaccination 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Foot and Mouth Disease (FMD) Vaccination Distributors &nbsp;11.3 Foot and Mouth Disease (FMD) Vaccination Customer 12 World Forecast Review for Foot and Mouth Disease (FMD) Vaccination by Geographic Region &nbsp;12.1 Global Foot and Mouth Disease (FMD) Vaccination Market Size Forecast by Region &nbsp;12.1.1 Global Foot and Mouth Disease (FMD) Vaccination Forecast by Region (2026-2031) &nbsp;12.1.2 Global Foot and Mouth Disease (FMD) Vaccination Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Foot and Mouth Disease (FMD) Vaccination Forecast by Type (2026-2031) &nbsp;12.7 Global Foot and Mouth Disease (FMD) Vaccination Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Jinyu Group &nbsp;13.1.1 Jinyu Group Company Information &nbsp;13.1.2 Jinyu Group Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Jinyu Group Main Business Overview &nbsp;13.1.5 Jinyu Group Latest Developments &nbsp;13.2 Cavet Bio &nbsp;13.2.1 Cavet Bio Company Information &nbsp;13.2.2 Cavet Bio Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Cavet Bio Main Business Overview &nbsp;13.2.5 Cavet Bio Latest Developments &nbsp;13.3 CAHIC &nbsp;13.3.1 CAHIC Company Information &nbsp;13.3.2 CAHIC Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.3.3 CAHIC Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 CAHIC Main Business Overview &nbsp;13.3.5 CAHIC Latest Developments &nbsp;13.4 Tecon Group &nbsp;13.4.1 Tecon Group Company Information &nbsp;13.4.2 Tecon Group Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Tecon Group Main Business Overview &nbsp;13.4.5 Tecon Group Latest Developments &nbsp;13.5 Shen Lian &nbsp;13.5.1 Shen Lian Company Information &nbsp;13.5.2 Shen Lian Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.5.3 Shen Lian Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Shen Lian Main Business Overview &nbsp;13.5.5 Shen Lian Latest Developments &nbsp;13.6 Biogenesis Bag� &nbsp;13.6.1 Biogenesis Bag� Company Information &nbsp;13.6.2 Biogenesis Bag� Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.6.3 Biogenesis Bag� Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Biogenesis Bag� Main Business Overview &nbsp;13.6.5 Biogenesis Bag� Latest Developments &nbsp;13.7 BIGVET Biotech &nbsp;13.7.1 BIGVET Biotech Company Information &nbsp;13.7.2 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.7.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 BIGVET Biotech Main Business Overview &nbsp;13.7.5 BIGVET Biotech Latest Developments &nbsp;13.8 Indian Immunologicals &nbsp;13.8.1 Indian Immunologicals Company Information &nbsp;13.8.2 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.8.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Indian Immunologicals Main Business Overview &nbsp;13.8.5 Indian Immunologicals Latest Developments &nbsp;13.9 Boehringer Ingelheim &nbsp;13.9.1 Boehringer Ingelheim Company Information &nbsp;13.9.2 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Boehringer Ingelheim Main Business Overview &nbsp;13.9.5 Boehringer Ingelheim Latest Developments &nbsp;13.10 MSD Animal Health &nbsp;13.10.1 MSD Animal Health Company Information &nbsp;13.10.2 MSD Animal Health Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 MSD Animal Health Main Business Overview &nbsp;13.10.5 MSD Animal Health Latest Developments &nbsp;13.11 CEVA &nbsp;13.11.1 CEVA Company Information &nbsp;13.11.2 CEVA Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.11.3 CEVA Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 CEVA Main Business Overview &nbsp;13.11.5 CEVA Latest Developments &nbsp;13.12 Bayer HealthCare &nbsp;13.12.1 Bayer HealthCare Company Information &nbsp;13.12.2 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.12.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Bayer HealthCare Main Business Overview &nbsp;13.12.5 Bayer HealthCare Latest Developments &nbsp;13.13 VECOL &nbsp;13.13.1 VECOL Company Information &nbsp;13.13.2 VECOL Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.13.3 VECOL Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 VECOL Main Business Overview &nbsp;13.13.5 VECOL Latest Developments &nbsp;13.14 Sanofi (Merial) &nbsp;13.14.1 Sanofi (Merial) Company Information &nbsp;13.14.2 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.14.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Sanofi (Merial) Main Business Overview &nbsp;13.14.5 Sanofi (Merial) Latest Developments &nbsp;13.15 Brilliant Bio Pharma &nbsp;13.15.1 Brilliant Bio Pharma Company Information &nbsp;13.15.2 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.15.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Brilliant Bio Pharma Main Business Overview &nbsp;13.15.5 Brilliant Bio Pharma Latest Developments &nbsp;13.16 VETAL &nbsp;13.16.1 VETAL Company Information &nbsp;13.16.2 VETAL Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.16.3 VETAL Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 VETAL Main Business Overview &nbsp;13.16.5 VETAL Latest Developments &nbsp;13.17 BVI &nbsp;13.17.1 BVI Company Information &nbsp;13.17.2 BVI Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.17.3 BVI Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.17.4 BVI Main Business Overview &nbsp;13.17.5 BVI Latest Developments &nbsp;13.18 LIMOR &nbsp;13.18.1 LIMOR Company Information &nbsp;13.18.2 LIMOR Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.18.3 LIMOR Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.18.4 LIMOR Main Business Overview &nbsp;13.18.5 LIMOR Latest Developments &nbsp;13.19 ME VAC &nbsp;13.19.1 ME VAC Company Information &nbsp;13.19.2 ME VAC Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.19.3 ME VAC Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.19.4 ME VAC Main Business Overview &nbsp;13.19.5 ME VAC Latest Developments &nbsp;13.20 Agrovet &nbsp;13.20.1 Agrovet Company Information &nbsp;13.20.2 Agrovet Foot and Mouth Disease (FMD) Vaccination Product Portfolios and Specifications &nbsp;13.20.3 Agrovet Foot and Mouth Disease (FMD) Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.20.4 Agrovet Main Business Overview &nbsp;13.20.5 Agrovet Latest Developments 14 Research Findings and Conclusion

Report	Global Foot and Mouth Disease (FMD) Vaccination Market Growth 2025-2031
Selected License	Multi ID: LPI13665

Buyer Information

Order Summary